List of Tables
Table 1. Global Anti-PCSK9 Monoclonal Antibody Market Size Growth Rate by Type, 2019 VS 2023 VS 2030 (US$ Million)
Table 2. Major Manufacturers of Alizumab
Table 3. Major Manufacturers of Evolocumab
Table 4. Global Anti-PCSK9 Monoclonal Antibody Market Size Growth Rate by Application, 2019 VS 2023 VS 2030 (US$ Million)
Table 5. Global Anti-PCSK9 Monoclonal Antibody Revenue Grow Rate (CAGR) by Region: 2019 VS 2023 VS 2030 (US$ Million)
Table 6. Global Anti-PCSK9 Monoclonal Antibody Revenue by Region (2019-2024) & (US$ Million)
Table 7. Global Anti-PCSK9 Monoclonal Antibody Revenue by Region (2025-2030) & (US$ Million)
Table 8. Global Anti-PCSK9 Monoclonal Antibody Revenue Market Share by Region (2019-2024)
Table 9. Global Anti-PCSK9 Monoclonal Antibody Revenue Market Share by Region (2025-2030)
Table 10. Global Anti-PCSK9 Monoclonal Antibody Sales Grow Rate (CAGR) by Region: 2019 VS 2023 VS 2030 (US$ Million)
Table 11. Global Anti-PCSK9 Monoclonal Antibody Sales by Region (2019-2024) & (KG)
Table 12. Global Anti-PCSK9 Monoclonal Antibody Sales by Region (2025-2030) & (KG)
Table 13. Global Anti-PCSK9 Monoclonal Antibody Sales Market Share by Region (2019-2024)
Table 14. Global Anti-PCSK9 Monoclonal Antibody Sales Market Share by Region (2025-2030)
Table 15. Global Anti-PCSK9 Monoclonal Antibody Sales by Manufacturers (2019-2024) & (KG)
Table 16. Global Anti-PCSK9 Monoclonal Antibody Sales Share by Manufacturers (2019-2024)
Table 17. Global Anti-PCSK9 Monoclonal Antibody Revenue by Manufacturers (2019-2024) & (US$ Million)
Table 18. Global Anti-PCSK9 Monoclonal Antibody Revenue Share by Manufacturers (2019-2024)
Table 19. Global Key Players of Anti-PCSK9 Monoclonal Antibody, Industry Ranking, 2022 VS 2023 VS 2024
Table 20. Anti-PCSK9 Monoclonal Antibody Price by Manufacturers 2019-2024 (USD/KG)
Table 21. Global Anti-PCSK9 Monoclonal Antibody Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 22. Global Anti-PCSK9 Monoclonal Antibody by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Anti-PCSK9 Monoclonal Antibody as of 2023)
Table 23. Global Key Manufacturers of Anti-PCSK9 Monoclonal Antibody, Manufacturing Base Distribution and Headquarters
Table 24. Global Key Manufacturers of Anti-PCSK9 Monoclonal Antibody, Product Offered and Application
Table 25. Global Key Manufacturers of Anti-PCSK9 Monoclonal Antibody, Date of Enter into This Industry
Table 26. Mergers & Acquisitions, Expansion Plans
Table 27. Global Anti-PCSK9 Monoclonal Antibody Sales by Type (2019-2024) & (KG)
Table 28. Global Anti-PCSK9 Monoclonal Antibody Sales by Type (2025-2030) & (KG)
Table 29. Global Anti-PCSK9 Monoclonal Antibody Sales Share by Type (2019-2024)
Table 30. Global Anti-PCSK9 Monoclonal Antibody Sales Share by Type (2025-2030)
Table 31. Global Anti-PCSK9 Monoclonal Antibody Revenue by Type (2019-2024) & (US$ Million)
Table 32. Global Anti-PCSK9 Monoclonal Antibody Revenue by Type (2025-2030) & (US$ Million)
Table 33. Global Anti-PCSK9 Monoclonal Antibody Revenue Share by Type (2019-2024)
Table 34. Global Anti-PCSK9 Monoclonal Antibody Revenue Share by Type (2025-2030)
Table 35. Anti-PCSK9 Monoclonal Antibody Price by Type (2019-2024) & (USD/KG)
Table 36. Global Anti-PCSK9 Monoclonal Antibody Price Forecast by Type (2025-2030) & (USD/KG)
Table 37. Global Anti-PCSK9 Monoclonal Antibody Sales by Application (2019-2024) & (KG)
Table 38. Global Anti-PCSK9 Monoclonal Antibody Sales by Application (2025-2030) & (KG)
Table 39. Global Anti-PCSK9 Monoclonal Antibody Sales Share by Application (2019-2024)
Table 40. Global Anti-PCSK9 Monoclonal Antibody Sales Share by Application (2025-2030)
Table 41. Global Anti-PCSK9 Monoclonal Antibody Revenue by Application (2019-2024) & (US$ Million)
Table 42. Global Anti-PCSK9 Monoclonal Antibody Revenue by Application (2025-2030) & (US$ Million)
Table 43. Global Anti-PCSK9 Monoclonal Antibody Revenue Share by Application (2019-2024)
Table 44. Global Anti-PCSK9 Monoclonal Antibody Revenue Share by Application (2025-2030)
Table 45. Anti-PCSK9 Monoclonal Antibody Price by Application (2019-2024) & (USD/KG)
Table 46. Global Anti-PCSK9 Monoclonal Antibody Price Forecast by Application (2025-2030) & (USD/KG)
Table 47. US & Canada Anti-PCSK9 Monoclonal Antibody Sales by Type (2019-2024) & (KG)
Table 48. US & Canada Anti-PCSK9 Monoclonal Antibody Sales by Type (2025-2030) & (KG)
Table 49. US & Canada Anti-PCSK9 Monoclonal Antibody Revenue by Type (2019-2024) & (US$ Million)
Table 50. US & Canada Anti-PCSK9 Monoclonal Antibody Revenue by Type (2025-2030) & (US$ Million)
Table 51. US & Canada Anti-PCSK9 Monoclonal Antibody Sales by Application (2019-2024) & (KG)
Table 52. US & Canada Anti-PCSK9 Monoclonal Antibody Sales by Application (2025-2030) & (KG)
Table 53. US & Canada Anti-PCSK9 Monoclonal Antibody Revenue by Application (2019-2024) & (US$ Million)
Table 54. US & Canada Anti-PCSK9 Monoclonal Antibody Revenue by Application (2025-2030) & (US$ Million)
Table 55. US & Canada Anti-PCSK9 Monoclonal Antibody Revenue Grow Rate (CAGR) by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 56. US & Canada Anti-PCSK9 Monoclonal Antibody Revenue by Country (2019-2024) & (US$ Million)
Table 57. US & Canada Anti-PCSK9 Monoclonal Antibody Revenue by Country (2025-2030) & (US$ Million)
Table 58. US & Canada Anti-PCSK9 Monoclonal Antibody Sales by Country (2019-2024) & (KG)
Table 59. US & Canada Anti-PCSK9 Monoclonal Antibody Sales by Country (2025-2030) & (KG)
Table 60. Europe Anti-PCSK9 Monoclonal Antibody Sales by Type (2019-2024) & (KG)
Table 61. Europe Anti-PCSK9 Monoclonal Antibody Sales by Type (2025-2030) & (KG)
Table 62. Europe Anti-PCSK9 Monoclonal Antibody Revenue by Type (2019-2024) & (US$ Million)
Table 63. Europe Anti-PCSK9 Monoclonal Antibody Revenue by Type (2025-2030) & (US$ Million)
Table 64. Europe Anti-PCSK9 Monoclonal Antibody Sales by Application (2019-2024) & (KG)
Table 65. Europe Anti-PCSK9 Monoclonal Antibody Sales by Application (2025-2030) & (KG)
Table 66. Europe Anti-PCSK9 Monoclonal Antibody Revenue by Application (2019-2024) & (US$ Million)
Table 67. Europe Anti-PCSK9 Monoclonal Antibody Revenue by Application (2025-2030) & (US$ Million)
Table 68. Europe Anti-PCSK9 Monoclonal Antibody Revenue Grow Rate (CAGR) by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 69. Europe Anti-PCSK9 Monoclonal Antibody Revenue by Country (2019-2024) & (US$ Million)
Table 70. Europe Anti-PCSK9 Monoclonal Antibody Revenue by Country (2025-2030) & (US$ Million)
Table 71. Europe Anti-PCSK9 Monoclonal Antibody Sales by Country (2019-2024) & (KG)
Table 72. Europe Anti-PCSK9 Monoclonal Antibody Sales by Country (2025-2030) & (KG)
Table 73. China Anti-PCSK9 Monoclonal Antibody Sales by Type (2019-2024) & (KG)
Table 74. China Anti-PCSK9 Monoclonal Antibody Sales by Type (2025-2030) & (KG)
Table 75. China Anti-PCSK9 Monoclonal Antibody Revenue by Type (2019-2024) & (US$ Million)
Table 76. China Anti-PCSK9 Monoclonal Antibody Revenue by Type (2025-2030) & (US$ Million)
Table 77. China Anti-PCSK9 Monoclonal Antibody Sales by Application (2019-2024) & (KG)
Table 78. China Anti-PCSK9 Monoclonal Antibody Sales by Application (2025-2030) & (KG)
Table 79. China Anti-PCSK9 Monoclonal Antibody Revenue by Application (2019-2024) & (US$ Million)
Table 80. China Anti-PCSK9 Monoclonal Antibody Revenue by Application (2025-2030) & (US$ Million)
Table 81. Asia Anti-PCSK9 Monoclonal Antibody Sales by Type (2019-2024) & (KG)
Table 82. Asia Anti-PCSK9 Monoclonal Antibody Sales by Type (2025-2030) & (KG)
Table 83. Asia Anti-PCSK9 Monoclonal Antibody Revenue by Type (2019-2024) & (US$ Million)
Table 84. Asia Anti-PCSK9 Monoclonal Antibody Revenue by Type (2025-2030) & (US$ Million)
Table 85. Asia Anti-PCSK9 Monoclonal Antibody Sales by Application (2019-2024) & (KG)
Table 86. Asia Anti-PCSK9 Monoclonal Antibody Sales by Application (2025-2030) & (KG)
Table 87. Asia Anti-PCSK9 Monoclonal Antibody Revenue by Application (2019-2024) & (US$ Million)
Table 88. Asia Anti-PCSK9 Monoclonal Antibody Revenue by Application (2025-2030) & (US$ Million)
Table 89. Asia Anti-PCSK9 Monoclonal Antibody Revenue Grow Rate (CAGR) by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 90. Asia Anti-PCSK9 Monoclonal Antibody Revenue by Region (2019-2024) & (US$ Million)
Table 91. Asia Anti-PCSK9 Monoclonal Antibody Revenue by Region (2025-2030) & (US$ Million)
Table 92. Asia Anti-PCSK9 Monoclonal Antibody Sales by Region (2019-2024) & (KG)
Table 93. Asia Anti-PCSK9 Monoclonal Antibody Sales by Region (2025-2030) & (KG)
Table 94. Middle East, Africa and Latin America Anti-PCSK9 Monoclonal Antibody Sales by Type (2019-2024) & (KG)
Table 95. Middle East, Africa and Latin America Anti-PCSK9 Monoclonal Antibody Sales by Type (2025-2030) & (KG)
Table 96. Middle East, Africa and Latin America Anti-PCSK9 Monoclonal Antibody Revenue by Type (2019-2024) & (US$ Million)
Table 97. Middle East, Africa and Latin America Anti-PCSK9 Monoclonal Antibody Revenue by Type (2025-2030) & (US$ Million)
Table 98. Middle East, Africa and Latin America Anti-PCSK9 Monoclonal Antibody Sales by Application (2019-2024) & (KG)
Table 99. Middle East, Africa and Latin America Anti-PCSK9 Monoclonal Antibody Sales by Application (2025-2030) & (KG)
Table 100. Middle East, Africa and Latin America Anti-PCSK9 Monoclonal Antibody Revenue by Application (2019-2024) & (US$ Million)
Table 101. Middle East, Africa and Latin America Anti-PCSK9 Monoclonal Antibody Revenue by Application (2025-2030) & (US$ Million)
Table 102. Middle East, Africa and Latin America Anti-PCSK9 Monoclonal Antibody Revenue Grow Rate (CAGR) by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 103. Middle East, Africa and Latin America Anti-PCSK9 Monoclonal Antibody Revenue by Country (2019-2024) & (US$ Million)
Table 104. Middle East, Africa and Latin America Anti-PCSK9 Monoclonal Antibody Revenue by Country (2025-2030) & (US$ Million)
Table 105. Middle East, Africa and Latin America Anti-PCSK9 Monoclonal Antibody Sales by Country (2019-2024) & (KG)
Table 106. Middle East, Africa and Latin America Anti-PCSK9 Monoclonal Antibody Sales by Country (2025-2030) & (KG)
Table 107. Sanofi + Regeneron Company Information
Table 108. Sanofi + Regeneron Description and Major Businesses
Table 109. Sanofi + Regeneron Anti-PCSK9 Monoclonal Antibody Sales (KG), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2019-2024)
Table 110. Sanofi + Regeneron Anti-PCSK9 Monoclonal Antibody Product Model Numbers, Pictures, Descriptions and Specifications
Table 111. Sanofi + Regeneron Recent Developments
Table 112. Amgen Company Information
Table 113. Amgen Description and Major Businesses
Table 114. Amgen Anti-PCSK9 Monoclonal Antibody Sales (KG), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2019-2024)
Table 115. Amgen Anti-PCSK9 Monoclonal Antibody Product Model Numbers, Pictures, Descriptions and Specifications
Table 116. Amgen Recent Developments
Table 117. Key Raw Materials Lists
Table 118. Raw Materials Key Suppliers Lists
Table 119. Anti-PCSK9 Monoclonal Antibody Distributors List
Table 120. Anti-PCSK9 Monoclonal Antibody Customers List
Table 121. Anti-PCSK9 Monoclonal Antibody Market Trends
Table 122. Anti-PCSK9 Monoclonal Antibody Market Drivers
Table 123. Anti-PCSK9 Monoclonal Antibody Market Challenges
Table 124. Anti-PCSK9 Monoclonal Antibody Market Restraints
Table 125. Research Programs/Design for This Report
Table 126. Key Data Information from Secondary Sources
Table 127. Key Data Information from Primary Sources
List of Figures
Figure 1. Anti-PCSK9 Monoclonal Antibody Product Picture
Figure 2. Global Anti-PCSK9 Monoclonal Antibody Market Size Growth Rate by Type, 2019 VS 2023 VS 2030 (US$ Million)
Figure 3. Global Anti-PCSK9 Monoclonal Antibody Market Share by Type in 2023 & 2030
Figure 4. Alizumab Product Picture
Figure 5. Evolocumab Product Picture
Figure 6. Global Anti-PCSK9 Monoclonal Antibody Market Size Growth Rate by Application, 2019 VS 2023 VS 2030 (US$ Million)
Figure 7. Global Anti-PCSK9 Monoclonal Antibody Market Share by Application in 2023 & 2030
Figure 8. Hypercholesterolemia
Figure 9. Atherosclerotic Cardiovascular Disease
Figure 10. Others
Figure 11. Anti-PCSK9 Monoclonal Antibody Report Years Considered
Figure 12. Global Anti-PCSK9 Monoclonal Antibody Revenue, (US$ Million), 2019 VS 2023 VS 2030
Figure 13. Global Anti-PCSK9 Monoclonal Antibody Revenue 2019-2030 (US$ Million)
Figure 14. Global Anti-PCSK9 Monoclonal Antibody Revenue Market Share by Region in Percentage: 2023 Versus 2030
Figure 15. Global Anti-PCSK9 Monoclonal Antibody Revenue Market Share by Region (2019-2030)
Figure 16. Global Anti-PCSK9 Monoclonal Antibody Sales 2019-2030 ((KG)
Figure 17. Global Anti-PCSK9 Monoclonal Antibody Sales Market Share by Region (2019-2030)
Figure 18. US & Canada Anti-PCSK9 Monoclonal Antibody Sales YoY (2019-2030) & (KG)
Figure 19. US & Canada Anti-PCSK9 Monoclonal Antibody Revenue YoY (2019-2030) & (US$ Million)
Figure 20. Europe Anti-PCSK9 Monoclonal Antibody Sales YoY (2019-2030) & (KG)
Figure 21. Europe Anti-PCSK9 Monoclonal Antibody Revenue YoY (2019-2030) & (US$ Million)
Figure 22. China Anti-PCSK9 Monoclonal Antibody Sales YoY (2019-2030) & (KG)
Figure 23. China Anti-PCSK9 Monoclonal Antibody Revenue YoY (2019-2030) & (US$ Million)
Figure 24. Asia (excluding China) Anti-PCSK9 Monoclonal Antibody Sales YoY (2019-2030) & (KG)
Figure 25. Asia (excluding China) Anti-PCSK9 Monoclonal Antibody Revenue YoY (2019-2030) & (US$ Million)
Figure 26. Middle East, Africa and Latin America Anti-PCSK9 Monoclonal Antibody Sales YoY (2019-2030) & (KG)
Figure 27. Middle East, Africa and Latin America Anti-PCSK9 Monoclonal Antibody Revenue YoY (2019-2030) & (US$ Million)
Figure 28. The Anti-PCSK9 Monoclonal Antibody Market Share of Top 10 and Top 5 Largest Manufacturers Around the World in 2023
Figure 29. The Top 5 and 10 Largest Manufacturers of Anti-PCSK9 Monoclonal Antibody in the World: Market Share by Anti-PCSK9 Monoclonal Antibody Revenue in 2023
Figure 30. Global Anti-PCSK9 Monoclonal Antibody Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023
Figure 31. Global Anti-PCSK9 Monoclonal Antibody Sales Market Share by Type (2019-2030)
Figure 32. Global Anti-PCSK9 Monoclonal Antibody Revenue Market Share by Type (2019-2030)
Figure 33. Global Anti-PCSK9 Monoclonal Antibody Sales Market Share by Application (2019-2030)
Figure 34. Global Anti-PCSK9 Monoclonal Antibody Revenue Market Share by Application (2019-2030)
Figure 35. US & Canada Anti-PCSK9 Monoclonal Antibody Sales Market Share by Type (2019-2030)
Figure 36. US & Canada Anti-PCSK9 Monoclonal Antibody Revenue Market Share by Type (2019-2030)
Figure 37. US & Canada Anti-PCSK9 Monoclonal Antibody Sales Market Share by Application (2019-2030)
Figure 38. US & Canada Anti-PCSK9 Monoclonal Antibody Revenue Market Share by Application (2019-2030)
Figure 39. US & Canada Anti-PCSK9 Monoclonal Antibody Revenue Share by Country (2019-2030)
Figure 40. US & Canada Anti-PCSK9 Monoclonal Antibody Sales Share by Country (2019-2030)
Figure 41. U.S. Anti-PCSK9 Monoclonal Antibody Revenue (2019-2030) & (US$ Million)
Figure 42. Canada Anti-PCSK9 Monoclonal Antibody Revenue (2019-2030) & (US$ Million)
Figure 43. Europe Anti-PCSK9 Monoclonal Antibody Sales Market Share by Type (2019-2030)
Figure 44. Europe Anti-PCSK9 Monoclonal Antibody Revenue Market Share by Type (2019-2030)
Figure 45. Europe Anti-PCSK9 Monoclonal Antibody Sales Market Share by Application (2019-2030)
Figure 46. Europe Anti-PCSK9 Monoclonal Antibody Revenue Market Share by Application (2019-2030)
Figure 47. Europe Anti-PCSK9 Monoclonal Antibody Revenue Share by Country (2019-2030)
Figure 48. Europe Anti-PCSK9 Monoclonal Antibody Sales Share by Country (2019-2030)
Figure 49. Germany Anti-PCSK9 Monoclonal Antibody Revenue (2019-2030) & (US$ Million)
Figure 50. France Anti-PCSK9 Monoclonal Antibody Revenue (2019-2030) & (US$ Million)
Figure 51. U.K. Anti-PCSK9 Monoclonal Antibody Revenue (2019-2030) & (US$ Million)
Figure 52. Italy Anti-PCSK9 Monoclonal Antibody Revenue (2019-2030) & (US$ Million)
Figure 53. Russia Anti-PCSK9 Monoclonal Antibody Revenue (2019-2030) & (US$ Million)
Figure 54. China Anti-PCSK9 Monoclonal Antibody Sales Market Share by Type (2019-2030)
Figure 55. China Anti-PCSK9 Monoclonal Antibody Revenue Market Share by Type (2019-2030)
Figure 56. China Anti-PCSK9 Monoclonal Antibody Sales Market Share by Application (2019-2030)
Figure 57. China Anti-PCSK9 Monoclonal Antibody Revenue Market Share by Application (2019-2030)
Figure 58. Asia Anti-PCSK9 Monoclonal Antibody Sales Market Share by Type (2019-2030)
Figure 59. Asia Anti-PCSK9 Monoclonal Antibody Revenue Market Share by Type (2019-2030)
Figure 60. Asia Anti-PCSK9 Monoclonal Antibody Sales Market Share by Application (2019-2030)
Figure 61. Asia Anti-PCSK9 Monoclonal Antibody Revenue Market Share by Application (2019-2030)
Figure 62. Asia Anti-PCSK9 Monoclonal Antibody Revenue Share by Region (2019-2030)
Figure 63. Asia Anti-PCSK9 Monoclonal Antibody Sales Share by Region (2019-2030)
Figure 64. Japan Anti-PCSK9 Monoclonal Antibody Revenue (2019-2030) & (US$ Million)
Figure 65. South Korea Anti-PCSK9 Monoclonal Antibody Revenue (2019-2030) & (US$ Million)
Figure 66. China Taiwan Anti-PCSK9 Monoclonal Antibody Revenue (2019-2030) & (US$ Million)
Figure 67. Southeast Asia Anti-PCSK9 Monoclonal Antibody Revenue (2019-2030) & (US$ Million)
Figure 68. India Anti-PCSK9 Monoclonal Antibody Revenue (2019-2030) & (US$ Million)
Figure 69. Middle East, Africa and Latin America Anti-PCSK9 Monoclonal Antibody Sales Market Share by Type (2019-2030)
Figure 70. Middle East, Africa and Latin America Anti-PCSK9 Monoclonal Antibody Revenue Market Share by Type (2019-2030)
Figure 71. Middle East, Africa and Latin America Anti-PCSK9 Monoclonal Antibody Sales Market Share by Application (2019-2030)
Figure 72. Middle East, Africa and Latin America Anti-PCSK9 Monoclonal Antibody Revenue Market Share by Application (2019-2030)
Figure 73. Middle East, Africa and Latin America Anti-PCSK9 Monoclonal Antibody Revenue Share by Country (2019-2030)
Figure 74. Middle East, Africa and Latin America Anti-PCSK9 Monoclonal Antibody Sales Share by Country (2019-2030)
Figure 75. Brazil Anti-PCSK9 Monoclonal Antibody Revenue (2019-2030) & (US$ Million)
Figure 76. Mexico Anti-PCSK9 Monoclonal Antibody Revenue (2019-2030) & (US$ Million)
Figure 77. Turkey Anti-PCSK9 Monoclonal Antibody Revenue (2019-2030) & (US$ Million)
Figure 78. Israel Anti-PCSK9 Monoclonal Antibody Revenue (2019-2030) & (US$ Million)
Figure 79. GCC Countries Anti-PCSK9 Monoclonal Antibody Revenue (2019-2030) & (US$ Million)
Figure 80. Anti-PCSK9 Monoclonal Antibody Value Chain
Figure 81. Anti-PCSK9 Monoclonal Antibody Production Process
Figure 82. Channels of Distribution
Figure 83. Distributors Profiles
Figure 84. Bottom-up and Top-down Approaches for This Report
Figure 85. Data Triangulation
Figure 86. Key Executives Interviewed